Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Hiroko Gotoda"'
Autor:
Yoh Asahi, Takuto Suzuki, Akiufumi Sawada, Masaya Kina, Joji Takada, Hiroko Gotoda, Hiroyuki Masuko
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 2, Pp 432-438 (2018)
A 67-year-old man with liver and retroperitoneal metastases from a gastrointestinal stromal tumor arising in the jejunum had been administered oral sunitinib for 2 months. He presented to our department with right-sided lower abdominal pain. His gene
Externí odkaz:
https://doaj.org/article/f828876f466a40e194955050070d0913
Publikováno v:
Pathology International. 73:167-169
Publikováno v:
Nishi Nihon Hifuka. 82:343-347
Autor:
Hiroki Nakamoto, Toshiya Kamiyama, Yoshifumi Iwaguchi, Makoto Nishikawa, Takahisa Ishikawa, Akinobu Taketomi, Ryouzi Yokoyama, Hiroko Gotoda
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 44:82-89
Publikováno v:
Nishi Nihon Hifuka. 80:455-459
Autor:
Takuto Suzuki, Hiroyuki Masuko, Joji Takada, Hiroko Gotoda, Yoh Asahi, Akiufumi Sawada, Masaya Kina
Publikováno v:
Case Reports in Gastroenterology, Vol 12, Iss 2, Pp 432-438 (2018)
Case Reports in Gastroenterology
Case Reports in Gastroenterology
A 67-year-old man with liver and retroperitoneal metastases from a gastrointestinal stromal tumor arising in the jejunum had been administered oral sunitinib for 2 months. He presented to our department with right-sided lower abdominal pain. His gene
Autor:
Hiroko Gotoda, Hiroyuki Takahashi, Atsushi Ibata, Makiko Kagaya, Kenji Yanagisawa, Tomoyuki Minowa
Publikováno v:
Nishi Nihon Hifuka. 80:38-44
Autor:
Shin Ichihara, Hiroko Gotoda, Naohiko Shimoda, Takenori Takada, Takayoshi Demura, Yoshihumi Iwaguchi, Takaya Hioka
Publikováno v:
Cancer Medicine
Previous studies have indicated a possible relationship between increased prostate volume (PV) and decreased biopsy yield, although the mechanism involved is unclear. We evaluated 1650 patients who underwent template biopsy. The distribution of 993 c
Publikováno v:
Skin Cancer. 32:295-301
Autor:
Yoshinobu Maeda, Yuka Kato, Tomoki Tamura, Katsuyuki Kiura, Takehiro Tanaka, Eiki Ichihara, Koichi Ichimura, Kiichiro Ninomiya, Katsuyuki Hotta, Kadoaki Ohashi, Go Makimoto, Hiroko Gotoda, Toshio Kubo
Publikováno v:
Biochemical and Biophysical Research Communications. 495:360-367
Although epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are a key therapy used for patients with EGFR-mutant non-small cell lung cancer (NSCLC), some of whom do not respond well to its therapy. Cytokine including IL-6 secrete